A research study conducted by Koot et al. revealed that the inclusion of a GnRH antagonist in a GnRH-a protocol substantially enhanced the pregnancy rate among individuals undergoing ART, while also reducing the risks associated with OHSS and multiple pregnancies [30]. Here, GNRH1 is linked to ovarian hyperstimulation syndrome.